
Tris Pharma will examine the efficacy and safety of cebranopadol in the ALLEVIATE-1 and ALLEVIATE-2 studies.

Tris Pharma will examine the efficacy and safety of cebranopadol in the ALLEVIATE-1 and ALLEVIATE-2 studies.

Check out this list of our top 10 stories from August 2024.

Researchers addressed the association of COVID-19 pandemic-related school disruptions with children’s incidence of acute psychiatric emergencies.

The government said the tests will “detect current COVID-19 variants and can be used through the end of the year.”

Check out these top featured stories from Drug Topics in August 2024.

The Stelo glucose biosensor system is intended for use in adults who do not use insulin or in those without diabetes who wish to better understand how diet and exercise affect blood glucose levels.

“While seasonal variation exists, it is expected that seniors will continue to benefit from flu vaccines that are stronger than the traditional standard-dose vaccines,” wrote investigators.

Check out these featured Drug Topics interviews from August 2024.

In case you missed it, this week we had news about illegal online GLP-1 sales, pharmacy deserts, innovative medication cooling technologies, and more.

Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.

Researchers analyzed data from every county in the US and aimed to address the association between high social vulnerability and pharmacy deserts.

Check out important updates from the FDA for the week of August 19.

Dana Krug, Senior Vice President of Cold Chain Fulfillment at Phononic, discussed the importance of cooling medications in the rising heat of the summer months.

Access inequities are preventing the US-affiliated Pacific Island (USAPI) jurisdictions from meeting the WHO 2030 goal of 90% human papillomavirus (HPV) vaccination series completion coverage.

Dana Krug, Senior Vice President of Cold Chain Fulfillment at Phononic, discussed the role his company’s technology plays in the pharmaceutical industry.

Increased incidence of typed 2 diabetes was associated with higher consumption of processed meat, unprocessed red meat, and poultry.

A detailed report of study findings will be published in a peer-reviewed journal and presented at ObesityWeek 2024.

Timothy Mackey, MAS, PhD, discusses a study that sought to determine the risk of sourcing semaglutide from online platforms.

Research experts at the Brookings Institution in Washington, D.C., analyzed the savings estimates provided by CMS for its drug price negotiations and compared them with the institution’s own estimates.

FDA approval of Amneal Pharmaceuticals' propofol injectable emulsion single-dose vials aims to address the drug’s history of chronic supply issues.

The approval of apremilast to treat plaque psoriasis in children and adolescents aged 6 years and older was based on data from the phase 3 SPROUT trial.

Final approval of the therapy may occur after expiration of the 3-year regulatory exclusivity for Tyvaso DPI on May 23, 2025.

The American Pharmacists Association is dedicating further time and resources to its ongoing fight for federal PBM reform.

Focus group participants were receptive to using eHealth tools, but noted several barriers such as cost and availability.

Participants were asked to rate their level of concern on 26 health topics.

In case you missed it, this week we had news about digital therapeutics for depression, bracing for fall allergies, at-home tests for sexually transmitted infections, and more.

First To Know Syphilis Tests are expected to be available at major national retailers and online in late 2024.

Tom DePietro, PharmD, owner of DePietro’s Pharmacy in Dunmore, Pennsylvania, discussed his experience as an independent pharmacy owner working under the thumb of pharmacy benefit managers.

Check out important updates from the FDA for the week of August 12.

The partnership’s revolutionary new product is set to premiere at the National Association of Chain Drug Stores’ Total Store Expo in Boston, Massachusetts, kicking off on August 17, 2024.